Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7321 AL 7335

Prospects of induced pluripotent stem cells in treating advancing Alzheimer's disease: A review

Park JJ, Rim YA, Sohn Y, Nam Y, Ju JH.

Histol Histopathol. 2025 Feb;40(2):157-170. doi: 10.14670/HH-18-766. Epub 2024 May 21.

Advanced nano delivery system for stem cell therapy for Alzheimer's disease

Pan Y, Li L, Cao N, Liao J, Chen H, Zhang M.

Biomaterials. 2025 Mar;314:122852. doi: 10.1016/j.biomaterials.2024.122852. Epub 2024 Sep 30.

Inflammatory signaling pathways in Alzheimer's disease: Mechanistic insights and possible therapeutic interventions

Almutary AG, Begum MY, Kyada AK, Gupta S, Jyothi SR, Chaudhary K, Sharma S, Sinha A, Abomughaid MM, Imran M, Lakhanpal S, Babalghith AO, Abu-Seer EA, Avinash D, Alzahrani HA, Alhindi AA, Iqbal D, Kumar S, Jha NK, Alghamdi S.

Ageing Res Rev. 2025 Feb;104:102548. doi: 10.1016/j.arr.2024.102548. Epub 2024 Oct 16.

Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer's disease

Karati D, Meur S, Roy S, Mukherjee S, Debnath B, Jha SK, Sarkar BK, Naskar S, Ghosh P.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2319-2342. doi: 10.1007/s00210-024-03500-1. Epub 2024 Oct 21.

Novel Emerging Targets Identification in Reducing Risk of Alzheimer's Disease

Sharma S, Rahate K, Kumar R.

Cent Nerv Syst Agents Med Chem. 2025;25(4):454-474. doi: 10.2174/0118715249333381241012073557.

Different physical exercise in the treatment of Alzheimer's disease

Deng T, Yu W, Lü Y.

Psychogeriatrics. 2025 Jan;25(1):e13207. doi: 10.1111/psyg.13207. Epub 2024 Oct 26.

Therapeutic Potential of Polyphenols in Cellular Reversal of Patho-Mechanisms of Alzheimer's Disease Using In Vitro and In Vivo Models: A Comprehensive Review

Samal M, Srivastava V, Khan M, Insaf A, Penumallu NR, Alam A, Parveen B, Ansari SH, Ahmad S.

Phytother Res. 2025 Jan;39(1):25-50. doi: 10.1002/ptr.8344. Epub 2024 Nov 4.

Amyloid-beta antibody treatment in Alzheimer's disease : An update on recent data and outlook on implementation in clinical routine

Stögmann E, Schmidt R.

Wien Klin Wochenschr. 2025 Mar;137(5-6):182-188. doi: 10.1007/s00508-024-02466-7. Epub 2024 Nov 6.

Application of carbon-based nanomaterials in Alzheimer's disease

Bai M, Shao X, Wang C, Wang J, Wang X, Guan P, Hu X.

Mater Horiz. 2025 Feb 3;12(3):673-693. doi: 10.1039/d4mh01256a.

The Contribution of the Renin-Angiotensin System to Alzheimer's Disease

Güzel Ö, Kehoe PG.

Curr Top Behav Neurosci. 2025;69:107-127. doi: 10.1007/7854_2024_525.

Exploring DPP IV inhibitors for Alzheimer's disease: Bridging diabetes and neurodegeneration

Pattanaik S, Prusty SK, Sahu PK.

Brain Res. 2025 Feb 1;1848:149342. doi: 10.1016/j.brainres.2024.149342. Epub 2024 Nov 19.

Calcium balance through mutual orchestrated inter-organelle communication: A pleiotropic target for combating Alzheimer's disease

Hossain MK, Chae HJ.

Neurochem Int. 2025 Jan;182:105905. doi: 10.1016/j.neuint.2024.105905. Epub 2024 Nov 19.

Recent advances in Alzheimer's disease therapy: clinical trials and literature review of novel enzyme inhibitors targeting amyloid precursor protein

Antony D, Sheth P, Swenson A, Smoller C, Maguire K, Grossberg G.

Expert Opin Pharmacother. 2025 Jan;26(1):63-73. doi: 10.1080/14656566.2024.2438317. Epub 2024 Dec 4.

Advances in the structural modification of Alzheimer's disease drug - Huperzine A

Zhu X, Xu JB, Gao F, Wan LX.

Bioorg Chem. 2025 Jan;154:108012. doi: 10.1016/j.bioorg.2024.108012. Epub 2024 Nov 29.

Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond

Sandhof CA, Murray HFB, Silva MC, Haggarty SJ.

Neurotherapeutics. 2025 Apr;22(3):e00499. doi: 10.1016/j.neurot.2024.e00499. Epub 2024 Dec 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias